Among patients with stage IIIA NSCLC, median OS was 56 months (95% CI: 26.1–not reached) for patients with PD-L1 TC <25% and was not reached for those with PD-L1 TC ≥25%. Here, CD274 is linked to non-small cell lung carcinoma.